Hengrui Pharma Unit Secures China Nod For Diabetes Drug Application

Jiangsu Hengrui Pharmaceuticals unit Shandong Shengdi received regulatory acceptance in China for the marketing application of its HRS-7535 tablets.

The drug is indicated for blood sugar .